Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: Standard vs half albumin doses. A prospective, randomized, unblinded pilot study

Digestive and Liver Disease

Volumn 43, Issue 11, 2011, Pages 881-886

  Alessandria, Carlo ^a   Elia, Chiara ^a   Mezzabotta, Lavinia ^a   Risso, Alessandro ^a   Andrealli, Alida ^a   Spandre, Maurizio ^a   Morgando, Anna ^a   Marzano, Alfredo ^a   Rizzetto, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Albumin; Ascites; Circulatory dysfunction; Cirrhosis; Paracentesis

Indexed keywords

ALBUMIN; ALDOSTERONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; FUROSEMIDE; PROPRANOLOL; RENIN; SODIUM; SPIRONOLACTONE;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; ASCITES; BANDAGING TECHNIQUE; BLEEDING; BRAIN DISEASE; CREATININE BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; HYPONATREMIA; INFECTION COMPLICATION; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORBIDITY; PARACENTESIS; PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION; PLASMA RENIN ACTIVITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SODIUM BLOOD LEVEL; SURVIVAL RATE; VARICOSIS;

ADULT; AGED; ALBUMINS; ASCITES; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPONATREMIA; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARACENTESIS; PILOT PROJECTS; PLASMA SUBSTITUTES; RECURRENCE; RENAL INSUFFICIENCY;

EID: 80052944591     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.06.001     Document Type: Article

References (24)

1. Runyon B.A. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009, 49:2087-2107. AASLD Practice Guidelines Committee.
2. Moore K.P., Wong F., Ginès P., et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003, 38:258-266.
3. Gines P., Arroyo V., Quintero E., et al. Comparison between paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of randomized study. Gastroenterology 1987, 93:234-241.
4. Garcia-Tsao G., Lim J.K. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009, 104:1802-1829. Members of Veterans Affairs Hepatitis C Resource Center Program.
5. Sola-Vera J., Such J. Understanding the mechanisms of paracentesis-induced circulatory dysfunction. Eur J Gastroenterol Hepatol 2004, 16:295-298.
6. Ginès A., Fernández-Esparrach G., Monescillo A., et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996, 111:1002-1010.
7. Coll S., Vila M.C., Molina L., et al. Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction. Eur J Gastroenterol Hepatol 2004, 16:347-353.
8. Cabrera J., Falcon L., Gorriz E., et al. Abdominal decompression plays a major role in early postparacentesis haemodynamic changes in cirrhotic patients with tense ascites. Gut 2001, 48:384-389.
9. Ginès P., Titó L., Arroyo V., et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988, 94:1493-1502.
10. Salerno F., Badalamenti S., Lorenzano E., et al. Randomized comparative study of Hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991, 13:707-713.
11. Planas R., Ginès P., Arroyo V., et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 1990, 99:1736-1744.
12. García-Compean D., Blanc P., Larrey D., et al. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial. Ann Hepatol 2002, 1:29-35.
13. Sola-Vera J., Miñana J., Ricart E., et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003, 37:1147-1153.
14. Moreau R., Asselah T., Condat B., et al. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Gut 2002, 50:90-94.
15. Singh V., Kumar R., Nain C.K., et al. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. J Gastroenterol Hepatol 2006, 21:303-307.
16. Singh V., Kumar B., Nain C.K., et al. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study. J Intern Med 2006, 260:62-68.
17. Singh V., Dheerendra P.C., Singh B., et al. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. Am J Gastroenterol 2008, 103:1399-1405.
18. Appenrodt B., Wolf A., Grünhage F., et al. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. Liver Int 2008, 28:1019-1025.
19. Karwa R., Woodis C.B. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications. Ann Pharmacother 2009, 43:692-699.
20. Tito L., Gines P., Arroyo V., et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology 1990, 98:146-151.
21. Gines P., Arroyo V., Vargas V., et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991, 325:829-835.
22. Ruiz-del-Arbol L., Monescillo A., Jimenez W., et al. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997, 113:579-586.
23. Cardenas A., Gines P., Runyon B.A. Is albumin infusion necessary after large volume paracentesis?. Liver Int 2009, 29:636-640.
24. Llach J., Ginès P., Arroyo V., et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988, 94:482-487.